Niro Narendran
Papers
1
Total Citations
12
H-Index
1
About
Dr. Niro Narendran is a leading ophthalmology researcher whose work centers on neovascular age-related macular degeneration (nAMD), a primary cause of blindness. His most significant contribution is the pivotal STAR trial, a randomized, double-masked, sham-controlled study evaluating stereotactic radiotherapy as a novel treatment for nAMD. This landmark 2024 trial, which has already garnered 12 citations, demonstrated that ionizing radiation can mitigate key pathogenic processes underlying the disease, offering a potential alternative or adjunct to the standard anti-VEGF injections. By rigorously testing this device-based approach, Dr. Narendran has advanced the field toward more durable, less invasive therapies for patients requiring frequent intraocular injections. His research addresses a critical unmet need in retinal disease management, and the STAR trial’s robust methodology sets a new benchmark for evaluating emerging treatments. With this work, Dr. Narendran has established himself as a key figure in the quest to reduce the treatment burden for nAMD patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1